Global Hormone Replacement Therapy (HRT) Market to Reach $40.1 Billion by 2030
The global market for Hormone Replacement Therapy (HRT) estimated at US$24.5 Billion in the year 2022, is projected to reach a revised size of US$40.1 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2022-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is projected to record a 6.4% CAGR and reach US$21.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Human Growth Hormone Replacement Therapy segment is readjusted to a revised 7.5% CAGR for the next 8-year period.The U.S. Market is Estimated at $7.2 Billion, While China is Forecast to Grow at 5.9% CAGR
The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$7.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$7 Billion by the year 2030 trailing a CAGR of 5.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.Select Competitors (Total 47 Featured) -
- Abbott Laboratories
- Allergan Plc
- Bayer AG
- Novartis AG
- Noven Pharmaceuticals Inc.
- Novo Nordisk A/S
- Pfizer Inc.
- TherapeuticsMD Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Allergan Plc
- Bayer AG
- Novartis AG
- Noven Pharmaceuticals Inc.
- Novo Nordisk A/S
- Pfizer Inc.
- TherapeuticsMD Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 276 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 24.5 Billion |
Forecasted Market Value ( USD | $ 40.1 Billion |
Compound Annual Growth Rate | 6.4% |
Regions Covered | Global |